BOVILIS Coronavirus (Canada)

Company: Merck Animal Health

Bovine Coronavirus Vaccine, Modified Live Virus

Cattle Vaccine

BOVILIS Coronavirus Indications

BOVILIS^® Coronavirus is recommended for use in healthy calves as an aid in the reduction of enteric disease caused by bovine coronavirus. Efficacy was demonstrated in calves 3 days of age and older, and safety has been demonstrated in calves 1 day of age and older.

Dosage and Administration

Transfer entire contents of the diluent vial into the vaccine vial, using aseptic technique and sterile syringes and needles. Administer 2 mL intranasally.

FOR INTRANASAL USE ONLY

FOR ANIMAL USE ONLY

BOVILIS Coronavirus Caution

Store at 2°-7°C (35°-45°F). Use entire contents when first opened. Do not use chemical disinfectants to sterilize syringes or needles. Dispose of containers and all unused vaccine according to local biohazardous waste disposal regulations. Do not vaccinate within 21 days before slaughter. Anaphylactoid reactions may occur following use. If allergic reaction occurs, treat with epinephrine. Contains penicillin and streptomycin as preservatives.

Intervet Inc., Merck Animal Health, division of Intervet Inc., Omaha, NE 68103, USA

U.S. Veterinary License No. 165A

1 866 683-7838 (Canada)

CPN: 1208286.1